1. The Value of Improving the Productivity of the Drug Development Process

   • Joseph A. DiMasi

   Original Research Article 17 September 2012 Pages: 1 - 10

   

2. Returns on Research and Development for 1990s New Drug Introductions

   • Henry Grabowski
   • John Vernon
   • Joseph A. DiMasi

   Original Research Article 17 September 2012 Pages: 11 - 29

   

3. A Profile of the Health Sector in the United States

   • Grace-Marie Turner

   Current Opinion 17 September 2012 Pages: 31 - 45

4. Meeting the Challenges to European Healthcare

   • Johan Hjertqvist

   Current Opinion 17 September 2012 Pages: 47 - 53

5. The Prospects for Reform of the Japanese Healthcare System

   • Tadahiko Tokita

   Current Opinion 17 September 2012 Pages: 55 - 66

   

6. Balancing the Cost and Value of Medications

   • Jerry Avorn

   Current Opinion 17 September 2012 Pages: 67 - 72

7. The Ågrenska Centre

   • Anders Olauson

   Current Opinion 17 September 2012 Pages: 73 - 75

8. The Role of Marketing in Pharmaceutical Research and Development

   • John E. Calfee

   Review Article 17 September 2012 Pages: 77 - 85

9. Reimbursement and Cost Containment

   • Friedrich Breyer

   Current Opinion 17 September 2012 Pages: 87 - 94

   

10. National Institute for Clinical Excellence (NICE): Is Economic Appraisal Working?

    • Adrian Towse
    • Clive Pritchard

    Current Opinion 17 September 2012 Pages: 95 - 105

    

11. Concluding Remarks

    • Louis Lasagna

    Concluding Remarks 17 September 2012 Pages: 107 - 108